Annually more than 20,000 volunteer unrelated hematopoietic stem cell donations are undertaken. Living donors donate
their cells for patients in need of a transplant. Since 2002 donor safety has become a highly visible issue. In that time WMDA
has started up a reporting system for unrelated hematopoietic stem cell donations. It is important to reassure potential
donors that there are systems in place to protect them from adverse outcomes and that there is a continuous learning
system which is informed by global reporting. The next step to improve the system of reporting is to collaborate with
regulatory authorities in order to be able to disseminate information that has been validated by experts in the field and
regulators. Another next step might be to set up a similar system for donors who donate hematopoietic stem cells for their
family members.

In addition the ICT infrastructure in facilitating an unrelated search for a transplant needs to be upgraded in order to speed up the process to find a suitable stem cell source for a patient in need of a transplant. WMDA strives to accelerate the search and match process by improving the underlying ICT infrastructure, to ensure full traceability of stem cells from donor to transplant by implementing a global donor ID-number and to collect more information so that better matching results can be accomplished.

Unfortunately, not for each patient a match can be found, WMDA will strive to identify the gap and develop focused recruitment strategies for populations where patient need is growing.

To reduce the administrative burden on organisations facilitating transplants WMDA will work on tools to share knowledge on the import from hematopoietic stem cells from third countries.


The overarching goal of the SFP Coalition multiannual work programme between 2018 and 2021 is to prevent cancer and chronic diseases through smoking prevention at EU and national level with a special focus on young people and health in all policies.

The first year of our 2018-2021 multiannual plan will set the foundation for SFP’s four main multi-sectoral campaigns in the coming years, while delivering specific activities and achieving concrete deliverables in 2018. The key campaigns for 2018 will focus on the forthcoming revision of the Tobacco Tax Directive. In this context we will also work with society organisations to call on their governments to ratify the Illicit Trade Protocol and to monitor the implementation of the EU system for tracking and tracing of tobacco products.

SFP will also work on promoting the understanding and implementation of FCTC Article 20 and towards the inclusion of SDG Target 3.4 (reducing NCDs) and 3.a (implementation of the FCTC) in national development plans. SFP will support the implementation of the FCTC at national level through the provision and exchange of evidence-based materials in particular with regard to Art 5.3 (tobacco industry interference), Art 8 (smoke-free policies), and Art 11&13 (especially plain packaging and point of sale measures).


The Correlation Network (CN) is a European civil society network and centre of expertise in the field of drug use, harm reduction and social inclusion.

Overall objective of this proposal:
Improve the access to and the quality of harm reduction services for People Who Use Drugs (PWUD), including other related vulnerable and marginalised people and to enhance policies and practices that increase social inclusion.

This is achieved by the following strategic objectives
- Strengthen the network and the collaboration with its members and partners through an adequate and solid organisational network structure
- Monitor developments and collect information and evidence in the field of drug use and harm reduction, by involving the expertise of civil society organisations
- Strengthen capacities of the various players in the field of drug use and harm reduction and facilitate exchange between network members and partners
- Advocate for full coverage of harm reduction programmes in Europe, addressing both health and social aspects.

All CN activities will pay specific attention to Hepatitis C, new drug trends and drug patterns and overdose prevention.

Relevant CN outputs include : Sustainable network, Annual Monitoring Reports, Online knowledge and training hub, European Harm Reduction Conferences (2018/20), policy recommendations.

CN contributes to the Third Health Programme (THP) by promoting health (in particular harm reduction), prevent diseases (in particular drug-related diseases and infectious diseases such as HCV and HIV/AIDS), and foster supportive environments for healthy lifestyles (e.g. by reducing barriers to access health and social services).

CN contributes as well to the following THP priorities:
1.2. Drugs-related health damage, including information and prevention
1.3. HIV/AIDS, tuberculosis and hepatitis
2.2. Capacity-building against health threats in Member States, including, where appropriate, cooperation with neighbouring countries.
